Maria Marvich

Array ( [id] => 5953228 [patent_doc_number] => 20110033930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'METHOD FOR OBTAINING NGN3-EXPRESSING CELLS AND INSULIN PRODUCING-BETA CELLS' [patent_app_type] => utility [patent_app_number] => 12/937610 [patent_app_country] => US [patent_app_date] => 2009-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11029 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20110033930.pdf [firstpage_image] =>[orig_patent_app_number] => 12937610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6063330 [patent_doc_number] => 20110201119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'ALPHAVIRUS PACKAGING CELL LINES' [patent_app_type] => utility [patent_app_number] => 12/737791 [patent_app_country] => US [patent_app_date] => 2009-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7938 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201119.pdf [firstpage_image] =>[orig_patent_app_number] => 12737791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446077 [patent_doc_number] => 08288127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Protein expression systems' [patent_app_type] => utility [patent_app_number] => 12/512930 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37772 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12512930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624596 [patent_doc_number] => 20100034774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Serotype of adenovirus and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/460678 [patent_app_country] => US [patent_app_date] => 2009-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 41227 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034774.pdf [firstpage_image] =>[orig_patent_app_number] => 12460678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6426172 [patent_doc_number] => 20100151523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'REGULATED EXPRESSION OF RECOMBINANT PROTEINS FROM ADENO-ASSOCIATED VIRAL VECTORS' [patent_app_type] => utility [patent_app_number] => 12/495054 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11751 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20100151523.pdf [firstpage_image] =>[orig_patent_app_number] => 12495054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6304746 [patent_doc_number] => 20100068815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SITE-SPECIFIC RECOMBINATION SYSTEMS FOR USE IN EUKARYOTIC CELLS' [patent_app_type] => utility [patent_app_number] => 12/494772 [patent_app_country] => US [patent_app_date] => 2009-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23412 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068815.pdf [firstpage_image] =>[orig_patent_app_number] => 12494772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6165048 [patent_doc_number] => 20110195123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'METHODS, COMPOSITIONS AND SYSTEMS FOR LOCAL DELIVERY OF DRUGS' [patent_app_type] => utility [patent_app_number] => 13/000656 [patent_app_country] => US [patent_app_date] => 2009-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18995 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195123.pdf [firstpage_image] =>[orig_patent_app_number] => 13000656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483441 [patent_doc_number] => 20100008947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'PORCINE ADENOVIRUS E1 AND E4 REGIONS' [patent_app_type] => utility [patent_app_number] => 12/488475 [patent_app_country] => US [patent_app_date] => 2009-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 22857 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008947.pdf [firstpage_image] =>[orig_patent_app_number] => 12488475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8294250 [patent_doc_number] => 08222032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Cell lines and methods for producing proteins' [patent_app_type] => utility [patent_app_number] => 12/455736 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10145 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12455736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8712830 [patent_doc_number] => 08398969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Compositions and methods for the treatment of viral hepatitis' [patent_app_type] => utility [patent_app_number] => 12/475127 [patent_app_country] => US [patent_app_date] => 2009-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 7938 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12475127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7540218 [patent_doc_number] => 08058061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies' [patent_app_type] => utility [patent_app_number] => 12/433412 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5808 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058061.pdf [firstpage_image] =>[orig_patent_app_number] => 12433412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777961 [patent_doc_number] => 08853166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Neurotrophic factor MANF and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/433345 [patent_app_country] => US [patent_app_date] => 2009-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 35655 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12433345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234841 [patent_doc_number] => 20100266545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'OBLIGATELY ANAEROBIC MUTANT LACTIC ACID BACTERIUM AND PREPARATION METHOD THEREFOR, AND EXPRESSION VECTOR FUNCTIONING IN OBLIGATELY ANAEROBIC LACTIC ACID BACTERIUM' [patent_app_type] => utility [patent_app_number] => 12/426152 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11841 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266545.pdf [firstpage_image] =>[orig_patent_app_number] => 12426152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5496485 [patent_doc_number] => 20090264513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'EXPRESSION VECTOR' [patent_app_type] => utility [patent_app_number] => 12/425001 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24797 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264513.pdf [firstpage_image] =>[orig_patent_app_number] => 12425001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195488 [patent_doc_number] => 20110027242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHOD FOR PRODUCTION OF TRANSFECTED CELL' [patent_app_type] => utility [patent_app_number] => 12/934843 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11627 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027242.pdf [firstpage_image] =>[orig_patent_app_number] => 12934843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5943481 [patent_doc_number] => 20110104101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Immunotherapy for Unresectable Pancreatic Cancer' [patent_app_type] => utility [patent_app_number] => 12/920803 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7980 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104101.pdf [firstpage_image] =>[orig_patent_app_number] => 12920803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5391165 [patent_doc_number] => 20090208478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'TRANSDUCIBLE POLYPEPTIDES FOR MODIFYING METABOLISM' [patent_app_type] => utility [patent_app_number] => 12/390225 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14122 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208478.pdf [firstpage_image] =>[orig_patent_app_number] => 12390225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385781 [patent_doc_number] => 20090227026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'TISSUE ENGINEERING SCAFFOLDS' [patent_app_type] => utility [patent_app_number] => 12/371522 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23617 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227026.pdf [firstpage_image] =>[orig_patent_app_number] => 12371522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343070 [patent_doc_number] => 20100330037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'ADENOVIRAL SYSTEMS AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/368121 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8173 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330037.pdf [firstpage_image] =>[orig_patent_app_number] => 12368121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422959 [patent_doc_number] => 20090149414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'rAAV EXPRESSION SYSTEMS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/363514 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 65738 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149414.pdf [firstpage_image] =>[orig_patent_app_number] => 12363514 [rel_patent_id] =>[rel_patent_doc_number] =>)